A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer

A systematic review was performed to evaluate the clinical effectiveness of docetaxel in combination with prednisolone (docetaxel is licensed in the UK for use in combination with prednisone or prednisolone for the treatment of patients with metastatic hormone-refractory prostate cancer. Prednisone...

Full description

Saved in:
Bibliographic Details
Main Authors: Collins, R, Trowman, R, Norman, G, Light, K, Birtle, A, Fenwick, E, Palmer, S, Riemsma, R
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2006
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360673/
https://ncbi.nlm.nih.gov/pubmed/16880788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603287
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items